FDA NDC Directory · JSON-LD · Markdown

Xultophy 100/3.6

NDC 0169-2911 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin degludec and liraglutide
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA208583
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN DEGLUDEC (100 [iU]/mL)
LIRAGLUTIDE (3.6 mg/mL)
Marketing started20161121
Package count1

External sources

Source: openFDA. Public-domain (CC0).